埃维纳库马布在耐火性高胆固醇血症患者的长期有效性和安全性
Robert S Rosenson1, Lesley J Burgess2, Christoph F Ebenbichler3
1Metabolism and Lipids Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York.
JAMA cardiology
|September 13, 2023
概括
埃维纳库马布在72周内显著降低了耐火性高胆固醇血症患者的LDL-C水平. 这种降脂疗法通常耐受良好,提供持续的心血管风险降低.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 耐药性高胆固醇血症增加了动脉样硬化心血管疾病 (ASCVD) 的风险.
- 最大耐受性降脂疗法 (LLT) 可能无法达到指导方针定义的低密度脂蛋白胆固醇 (LDL-C) 值.
研究的目的:
- 评估埃维纳库马布在耐火性高胆固醇血症患者的长期疗效和安全性.
- 评估持续的LDL-C降低和其他脂质参数与evinacumab治疗.
主要方法:
- 随机临床试验与双盲和开放标签治疗周期.
- 患者在48周的开放性治疗期间接受静脉注射埃维纳库马布 (15毫克/千克每4周一次).
- 通过LDL-C和其他脂质的变化来衡量有效性;通过治疗出现的不良事件来评估安全性.
主要成果:
- 埃维纳库马布 (15毫克/公斤) 在72.7周持续减少了45.5%的LDL-C.
- 观察到阿波利波蛋白B,非高密度脂蛋白胆固醇,总胆固醇和甘油三的显著降低.
- 治疗引起的不良事件发生在81.3%的患者中;严重事件是罕见的,与治疗无关.
结论:
- 埃维纳库马布在患有耐火性高胆固醇血症的患者中降低LDL-C的持续有效性.
- 药物一般耐受性很好,支持其在难以治疗的脂质疾病管理中的作用.
相关概念视频
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
696
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
696
Cholesterol: Significance and Regulation
580
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
580
Acute Coronary Syndrome III: Diagnostic Studies
9
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
13
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13
Atherosclerosis IV: Nursing Management
21
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
21


